|
⚲
|
| Keyboard |
| Hodges Philip
✚
|
|
|---|---|
| CIK # | 0001705562 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001705562] | |
| 4 | [0001705562] | |
| SC 13D | [0001705562] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Hodges Philip | Altimmune Inc | [2017-05-15] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Hodges Philip | |
| Pharmathene Inc | |
| Redmont VAXN Capital Holdings LLC | |
| Redmont Venture Partners Inc | |
| Paradigm Venture Partners LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pharmathene Inc ALT
Stock Options (option to buy) · derivative
|
2024-09-26 | Grant | 34,900 | $0.00 | |
|
Pharmathene Inc ALT
Stock Options (option to buy) · derivative
|
2023-09-28 | Grant | 26,100 | $0.00 | |
|
Pharmathene Inc ALT
Stock Options (option to buy) · derivative
|
2022-09-29 | Grant | 23,500 | $0.00 | |
|
Pharmathene Inc ALT
Stock Options (option to buy) · derivative
|
2021-09-23 | Grant | 24,100 | $0.00 | |
|
Pharmathene Inc ALT
Common Stock, par value $0.0001
|
2021-03-01 | Sell | 6,000 | $16.08 | 96,480 |
|
Pharmathene Inc ALT
Common Stock, par value $0.0001
|
2020-12-01 | Sell | 1,227 | $13.54 | 16,614 |
|
Pharmathene Inc ALT
Common Stock, par value $0.0001
|
2020-11-30 | Sell | 2,500 | $12.00 | 30,000 |
|
Pharmathene Inc ALT
"Restricted Stock Units (""RSUs"")" · derivative
|
2020-09-24 | Option exercise | 16,850 | $0.00 | |
|
Pharmathene Inc ALT
Common Stock, par value $0.0001
|
2020-09-24 | Option exercise | 16,850 | $0.00 | |
|
Pharmathene Inc ALT
Stock Options (option to buy) · derivative
|
2020-09-24 | Grant | 25,500 | $0.00 | |
|
Pharmathene Inc ALT
"Restricted Stock Units (""RSUs"")" · derivative
|
2020-06-25 | Grant | 16,850 | $0.00 | |
|
Pharmathene Inc ALT
Stock Options (option to buy) · derivative
|
2019-01-02 | Grant | 20,000 | $0.00 | |
|
Pharmathene Inc ALT
Common Stock, par value $0.0001
|
2017-10-17 | Other | 1,278,471 | $0.00 | |
|
Pharmathene Inc ALT
Stock Options (option to buy) · derivative
|
2017-10-13 | Grant | 20,000 | $0.00 | |
|
Pharmathene Inc NASDAQ:ALT
Common Stock, par value $0.0001
|
2017-05-04 | Grant | 4,455 | ||
|
Pharmathene Inc NASDAQ:ALT
Common Stock, par value $0.0001
|
2017-05-04 | Grant | 36,785 | ||
|
Pharmathene Inc NASDAQ:ALT
Common Stock, par value $0.0001
|
2017-05-04 | Grant | 1,278,471 |